CSPC Pharmaceuticals Group Ltd.
 
 
 
 
公司概覽
業務類別 --
業務概覽 CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.
公司地址 No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
電話號碼 +86 31187037015
傳真號碼 +86 31187039608
公司網頁 https://www.cspc.com.hk
員工數量 19700
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Cuilong Zhang Director and President -- 28/04/2026
Mr. Zhenguo Wang Director and President -- 28/04/2026
Mr. Huaiyu Wang Director and President -- 28/04/2026
Dr. Chunlei Li Director, President and Chief Scientist -- 28/04/2026
Mr. Xin Cai Director and President -- 28/04/2026
Mr. Weiping Chen Director and President -- 28/04/2026
Dr. Lei Cai Vice Chairman of the Board, President and Chief Executive Officer -- 28/04/2026
Mr. Qingjie Wei Vice Chairman of the Board, President and Chief Operating Officer -- 28/04/2026
Mr. Zhiyong Qu Director and President -- 28/04/2026
Mr. Yiwei Zhang Director and President -- 28/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Chun Kwok Alan Au Independent Director 28/04/2026
Mr. Cheuk Kin Stephen Law Independent Director 28/04/2026
Mr. Dongchen Cai Executive Chairman of the Board 28/04/2026
Mr. Cuilong Zhang Director and President 28/04/2026
Mr. Zhenguo Wang Director and President 28/04/2026
Mr. Huaiyu Wang Director and President 28/04/2026
Dr. Chunlei Li Director, President and Chief Scientist 28/04/2026
Mr. Bo Wang Independent Director 28/04/2026
Mr. Chuan Chen Independent Director 28/04/2026
Professor Hongguang Wang Independent Director 28/04/2026
Ms. Quan Li Independent Director 28/04/2026
Dr. Bing Yao Director 28/04/2026
Mr. Xin Cai Director and President 28/04/2026
Mr. Weiping Chen Director and President 28/04/2026
Dr. Lei Cai Vice Chairman of the Board, President and Chief Executive Officer 28/04/2026
Mr. Qingjie Wei Vice Chairman of the Board, President and Chief Operating Officer 28/04/2026
Mr. Zhiyong Qu Director and President 28/04/2026
Mr. Yiwei Zhang Director and President 28/04/2026
 
所屬ETF (更新日期: 18/07/2026 03:28)
代號 名稱 佔比% 持有日期
IEMGiShares Core MSCI Emerging Markets ETF0.78%30/06/2026
AVEMAvantis Emerging Markets Equity ETF0.49%30/06/2026
MCHIiShares MSCI China ETF0.17%30/06/2026
VEUVanguard FTSE All-Wld ex-US ETF0.16%30/06/2026
SPEMState Street® SPDR® Portfolio EM ETF0.12%30/06/2026
DFEMDimensional Emerging Markets Cr Eq 2 ETF0.11%30/06/2026
FNDESchwab Fundamental Emerging MarketsEqETF0.10%30/06/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.09%30/06/2026
SCHESchwab Emerging Markets Equity ETF™0.08%30/06/2026
EYLDCambria Emerging Shareholder Yield ETF0.08%30/06/2026
VYMIVanguard Intl Hi Div Yld Idx ETF0.07%30/06/2026
DFAEDimensional Emerging Core Equity Mkt ETF0.06%30/06/2026
VTVanguard Total World Stock ETF0.06%30/06/2026
DFAXDimensional World ex US Core Eq 2 ETF0.06%30/06/2026
AVESAvantis Emerging Markets Value ETF0.03%30/06/2026
KUREKraneShares MSCI All China Hlth Care ETF0.03%30/06/2026
AAXJiShares MSCI All Country Asia ex Jpn ETF0.02%30/06/2026
PXHInvesco RAFI Emerging Markets ETF0.02%30/06/2026
ACWIiShares MSCI ACWI ETF0.02%30/06/2026
ACWXiShares MSCI ACWI ex US ETF0.02%30/06/2026
 1    2    3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.